NOX

2.94%

6.6¢ noxopharm limited

Is this referring to the Blood Brain Barrier?

First 3 Last

Share
Profile

Follow
BoroBoyinoz

7,445 Posts.

1260

24/04/20

10:25

Post #: 44228956
Share

Originally posted by RBx ↑

Activating the immune system is not the challenge – a number of technologies readily do that including radiotherapy and CAR-T therapy. The challenge lies in those activated immune cells being able to access the tumour cells and one of the key ways that cancer avoids the immune system is by blocking immune cells gaining entry to the tumour. This problem is identified as the main barrier to the universal success of immuno-oncology therapy. Veyonda may be the first drug known to overcome this problem, potentially turning so-called ‘COLD’ (immune-deficient) tumours into ‘HOT’ (immune-competent) tumours. That potential puts Veyonda in the front-line of cancer therapies and one of the most exciting drug prospects to emerge in recent years.

Disclosure:

Pitt Street Research receives fees from the company referred to in this document, for research services and other financial services or advice we may provide to that company... As part of due diligence, the analyst has independently and critically reviewed the assistance and information provided by the company to form the opinions expressed in the report. Diligent care has been taken by the analyst to maintain an honest and fair objectivity in writing this report and making the recommendation.

Expand

Is this referring to the Blood Brain Barrier?

NOX Price at posting: 18.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

RCE

Recce's R327 found effective against E.coli during clinical trial

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

There are more pages in this discussion • 2 more messages in this thread...

First 3 Last

Add NOX (ASX) to my watchlist

(20min delay)
Last 6.6¢		Change -0.002(2.94%)		Mkt cap ! $19.28M

Open	High	Low	Value	Volume
6.7¢	6.9¢	6.6¢	$13.31K	198.1K

Buyers (Bids)

No.	Vol.	Price($)
1	1137	6.6¢

Sellers (Offers)

Price($)	Vol.	No.
6.7¢	22400	1

View Market Depth

No.	Vol.	Price($)
1	1137	0.066
1	100000	0.064
3	47786	0.061
4	105033	0.060
2	120000	0.059

Price($)	Vol.	No.
0.079	12000	2
0.080	12099	2
0.081	22345	2
0.083	40000	1
0.090	25689	3

Last trade - 15.50pm 28/06/2024 (20 minute delay)

NOX (ASX) Chart

Is this referring to the Blood Brain Barrier?

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Ava Risk Group expands US presence with A$0.7M Substation Deal

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Is this referring to the Blood Brain Barrier?

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Ava Risk Group expands US presence with A$0.7M Substation Deal

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News